CLONING OF INFLUENZA VIRAL RNA SEGMENTS

NIH RePORTER · NIH · R01 · $193,685 · view on reporter.nih.gov ↗

Abstract

Influenza is a major human disease without any effective prophylaxis or therapy. Every year influenza inflicts enormous human suffering in the form of increased morbidity and mortality. In addition, a staggering economic loss (nearly 4 billion dollars in the USA alone) is attributed directly to influenza. The goal of this project is to elucidate the property of this virus and its behavior at the genomic level and to investigate towards developing a better immunogen for prophylaxis. Therefore, we plan to continue studying influenza genes using recombinant DNA cloning technology and elucidate the primary and secondary structure of viral proteins. Furthermore, we plan to continue expressing the cloned DNAs using appropriate vectors in mammalian cells. We also want to make specific changes at the desired location, determine precisely the function of each domain of the viral proteins and elucidate the structure-function relationship. In addition, we want to express hemagglutinin and neuraminidase genes in yeast and explore newer ways to make a better subunit vaccine.

Key facts

NIH application ID
3126632
Project number
5R01AI016348-08
Recipient
UNIVERSITY OF CALIFORNIA LOS ANGELES
SAM.gov UEI
RN64EPNH8JC6
Principal Investigator
DEBI P. NAYAK
Activity code
R01
Funding institute
NIH
Fiscal year
1987
Award amount
$193,685
Award type
5
Project period
1980-05-01 → 1988-04-30